Research

UC San Francisco Department of Radiology and Biomedical Imaging is proud to announce that Duygu Tosun-Turgut, PhD, has been named a Distinguished Investigator by the Academy for Radiology & Biomedical Imaging Research. The award ceremony was held on November 29th during the Radiology Society of North America 2022 Scientific Assembly and Annual Meeting. 

Scientists at UCSF led by Olga Tymofiyeva, PhD conducted an individually randomized waitlist-controlled trial (RCT) with two objectives. The first was to test the feasibility of TARA, delivered partially over Zoom.

Investigators from the Hyperpolarized MRI Technology Resource Center (HMTRC) at UCSF set out to study whether hyperpolarized (HP) pyruvate MRI can a) detect cancer based on its metabolic reprogramming and b) whether it can assess tumor aggressiveness. 

Dr. Kondapa Bobba is one of eleven researchers awarded grants in support of cancer research projects in the spring 2022 cycle of the UCSF Resource Allocation Program (RAP). These awards are funded by agencies across UCSF and span a range of topics.

Priyanka Jha, MBBS recently led a team of investigators who studied the diagnostic performance of the Ovarian-Adnexal Reporting and Data System (O-RADS). They found that the ultrasound risk stratification system performed within the expected range specified by the American College of Radiology (ACR).

Joseph Leach, MD, PhD was part of a team of UCSF faculty based at the VAMC that examined the association between imaging-based AAA screening - both explicit and implicit - and various outcomes for approximately 1.6 million veterans in the VA health system over ten years (from 2005 to 2015).

Do head knocks eventually lead to Alzheimer's disease? Michael Weiner, MD set out to examine this question in Vietnam veterans.

Although the COVID-19 pandemic has profoundly disrupted many research studies, it has also accelerated development and use of remote assessment tools for cognition. The UCSF Brain Health Registry (BHR), an online research registry of over 100,000 adult volunteers, has been an innovator in this area and has continued to move forward.

The Bay Area Community Of Bay area RAdionuclide imagers (COBRA) meeting returned this year and was hosted at UC Davis on May 25, 2022. COBRA, originally conceived in 2006 by the late Bruce Hasegawa, PhD - brilliant investigator, educator and mentor at UCSF – and Ling Shao.

Recently, investigators from the Cancer Metabolic Imaging and Therapy Lab at the UC San Francisco Department of Radiology and Biomedical Imaging teamed up with the Department of Neurosurgery to identify metabolic alterations linked to this ALT pathway that can be exploited for non-invasive deuterium magnetic resonance spectroscopy (2H-MRS)-based imaging of astrocytomas in vivo.